Femme et Homme
- | Pays :
- Greece
- | Organes : -
- | Spécialités : -
Extrait
An open-label multi-center single-cohort study to assess the safety and efficacy of certolizumab pegol for the treatment of signs and symptoms of active Crohn's disease in Greek patients who have previously responded to infliximab but who no longer have a sustained response or became intolerant to infliximab
Critère d'inclusion
- Crohn’s Disease